TrialEuropean journal of cancer (Oxford, England : 1990)2025

Prognostic relation of body mass index on extended aromatase inhibition treatment in postmenopausal patients with estrogen receptor positive breast cancer: A retrospective analysis of the SOLE trial.

Giacomo Biganzoli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.